4FMFES-PET Imaging of Endometrial and Ovarian Cancers

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

August 31, 2023

Study Completion Date

April 30, 2024

Conditions

Endometrial CancerOvarian Cancer

Interventions

DRUG

Loperamide Pill

4 mg Imodium, per os

DRUG

hyoscine-n-butylbromide

3 X 20 mg Buscopan, intravenous

Trial Locations (1)

Centre de recherche du CHUS, Sherbrooke

All Listed Sponsors

collaborator

Université de Sherbrooke

OTHER

lead

Centre de recherche du Centre hospitalier universitaire de Sherbrooke

OTHER

NCT04823065 - 4FMFES-PET Imaging of Endometrial and Ovarian Cancers | Biotech Hunter | Biotech Hunter